RARS2
Basic information
Region (hg38): 6:87513459-87590028
Previous symbols: [ "RARSL" ]
Links
Phenotypes
GenCC
Source:
- pontocerebellar hypoplasia type 6 (Definitive), mode of inheritance: AR
- pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
- pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
- pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
- pontocerebellar hypoplasia type 6 (Supportive), mode of inheritance: AR
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
- pontocerebellar hypoplasia type 6 (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Pontocerebellar hypoplasia, type 6 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 17847012; 20635367; 22569581; 25809939 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (54 variants)
- Pontocerebellar hypoplasia type 6 (11 variants)
- Inborn genetic diseases (2 variants)
- Pontoneocerebellar hypoplasia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RARS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 179 | 182 | ||||
missense | 12 | 106 | 131 | |||
nonsense | 23 | 25 | 48 | |||
start loss | 8 | |||||
frameshift | 25 | 48 | 75 | |||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 48 | 56 | ||||
splice region | 1 | 1 | 10 | 48 | 4 | 64 |
non coding | 220 | 42 | 270 | |||
Total | 62 | 138 | 119 | 407 | 47 |
Highest pathogenic variant AF is 0.0000263
Variants in RARS2
This is a list of pathogenic ClinVar variants found in the RARS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-87514172-G-A | Benign (Jun 26, 2018) | |||
6-87514298-C-T | Benign (Jun 26, 2018) | |||
6-87514311-CA-C | Benign (Aug 10, 2019) | |||
6-87514311-C-CA | RARS2-related disorder | Benign (Aug 21, 2019) | ||
6-87514311-C-CAA | RARS2-related disorder | Likely benign (Apr 29, 2020) | ||
6-87514358-C-A | Likely benign (Jul 08, 2018) | |||
6-87514414-T-C | Likely benign (Nov 25, 2023) | |||
6-87514417-A-G | Inborn genetic diseases | Uncertain significance (Jan 26, 2022) | ||
6-87514425-T-TA | not specified • Pontocerebellar hypoplasia type 6 | Uncertain significance (Nov 11, 2013) | ||
6-87514428-A-T | Likely benign (May 21, 2022) | |||
6-87514432-G-A | not specified | Uncertain significance (Jan 03, 2022) | ||
6-87514437-T-G | Likely benign (May 17, 2023) | |||
6-87514442-G-A | Inborn genetic diseases • Pontocerebellar hypoplasia type 6 | Uncertain significance (Jan 06, 2022) | ||
6-87514446-T-C | not specified • Congenital disorder of glycosylation • Pontoneocerebellar hypoplasia • Pontocerebellar hypoplasia type 6 | Benign/Likely benign (Feb 01, 2024) | ||
6-87514458-G-C | Pontocerebellar hypoplasia type 6 | Likely benign (Jun 04, 2023) | ||
6-87514464-G-A | Likely benign (Jun 20, 2023) | |||
6-87514471-C-A | Uncertain significance (Jul 20, 2022) | |||
6-87514471-C-T | Pontocerebellar hypoplasia type 6 | Conflicting classifications of pathogenicity (Jun 26, 2024) | ||
6-87514472-G-A | Pontocerebellar hypoplasia type 6 | Conflicting classifications of pathogenicity (Jan 22, 2024) | ||
6-87514473-G-A | Likely benign (Jun 14, 2023) | |||
6-87514475-C-T | Pontocerebellar hypoplasia type 6 | Uncertain significance (Aug 14, 2020) | ||
6-87514476-A-G | Likely benign (Apr 10, 2021) | |||
6-87514496-T-C | Uncertain significance (Jun 10, 2021) | |||
6-87514501-T-C | Pontocerebellar hypoplasia type 6 | Pathogenic (Mar 14, 2024) | ||
6-87514507-A-G | Likely benign (Apr 28, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RARS2 | protein_coding | protein_coding | ENST00000369536 | 20 | 75626 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.74e-14 | 0.844 | 125645 | 0 | 103 | 125748 | 0.000410 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0650 | 308 | 305 | 1.01 | 0.0000159 | 3780 |
Missense in Polyphen | 101 | 118.72 | 0.85078 | 1392 | ||
Synonymous | -0.735 | 115 | 105 | 1.09 | 0.00000562 | 1068 |
Loss of Function | 1.95 | 27 | 40.3 | 0.669 | 0.00000204 | 472 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000941 | 0.000941 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000653 | 0.000653 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000502 | 0.000501 |
Middle Eastern | 0.000653 | 0.000653 |
South Asian | 0.000359 | 0.000359 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Disease
- DISEASE: Pontocerebellar hypoplasia 6 (PCH6) [MIM:611523]: A disorder characterized by an abnormally small cerebellum and brainstem, infantile encephalopathy, generalized hypotonia, lethargy and poor feeding. Recurrent apnea, intractable seizures occur early in the course of this condition. {ECO:0000269|PubMed:17847012}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);tRNA Aminoacylation;Translation;Metabolism of proteins;tRNA charging;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Mitochondrial tRNA aminoacylation
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.879
- rvis_EVS
- -0.13
- rvis_percentile_EVS
- 43.91
Haploinsufficiency Scores
- pHI
- 0.504
- hipred
- N
- hipred_score
- 0.476
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.964
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rars2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- rars2
- Affected structure
- midbrain hindbrain boundary
- Phenotype tag
- abnormal
- Phenotype quality
- dorso-ventrally flattened
Gene ontology
- Biological process
- tRNA aminoacylation for protein translation;arginyl-tRNA aminoacylation;mitochondrial translation
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;arginine-tRNA ligase activity;ATP binding